Reimagine life with Primary Periodic Paralysis
How Keveyis can help you
Gain greater control over PPP
When you live with PPP, you may feel like there’s a lot you can’t control. But KEVEYIS can help. It’s the first FDA-approved treatment for PPP proven to reduce the number, severity, and length of PPP episodes.1,2
In a clinical study, people taking KEVEYIS reported1,2:
-
PPP episodes decreased
Patients taking KEVEYIS had fewer episodes. -
PPP episodes were not as severe
Patients taking KEVEYIS reported that their episodes were not as severe. -
PPP episodes were shorter
When patients taking KEVEYIS did have episodes, they didn’t last as long.
“Having better control over my PPP symptoms has meant I can engage more fully in my life.”
Janine, KEVEYIS Patient and PPP Mentor
“I assumed my first call with my Patient Access Manager was only for educational purposes, but after I talked to him, I realized how much better I was feeling emotionally, just being able to have contact with someone who understood what I was going through.”
Dennis, KEVEYIS Patient and PPP Mentor
Get support
Find the support you need — right here
Managing PPP takes more than medication alone. We’ve been committed to supporting the PPP community for years. Through
Xeris CareConnection™, you can access a range of free support services. We’re not just experts — we’re your advocates.
-
Patient Access Managers
A dedicated, one-on-one resource who can help you navigate life with PPP, from understanding insurance coverage and calling the pharmacy to providing PPP education. -
Patient Mentors through PPP MentorConnect™
Real patients with PPP who currently take KEVEYIS and can share their experience with you.
DISEASE OVERVIEW
What is PPP?
PPP is a rare genetic condition that impacts your muscles and causes episodes of muscle weakness — and even temporary paralysis.3 The road to diagnosis can be difficult, and it’s often mistaken for other health issues.4
PATIENT TESTIMONIALS
Real KEVEYIS stories
Paul
KEVEYIS patient
Kirsten
KEVEYIS patient
Dennis
KEVEYIS patient
Janine
KEVEYIS patient
Take the next step
Get customized support for your KEVEYIS journey. Simply fill out the information and a Patient Access Manager will contact you. They will walk you through the entire process, from diagnosis to treatment and beyond.
By submitting this form, I understand I am giving Xeris Pharmaceuticals, Inc., its affiliates, and business partners permission to use the personal information provided in this registration form to contact me by the following methods, but not limited to: mail, email, telephone call or in-person about disease and product information, disease or product-related events, support services, market research, and to share promotional and marketing information. By submitting this form, I consent to these uses and am confirming that I have read and agree to the Xeris Pharmaceuticals® Terms of Use and Privacy Statement. I understand I can unsubscribe by clicking on the unsubscribe link in future communications or by sending a letter with my full contact information (eg, name, address, email, phone, etc) to Xeris CareConnection™ Patient Support Services, 1375 W Fulton Street, Suite 1300, Chicago, IL 60607.
References
- KEVEYIS [package insert]. Chicago, IL; Xeris Pharmaceuticals, Inc.
- Sansone VA, Burge J, McDermott MP, et al; for the Muscle Study Group. Randomized, placebo-controlled trials of dichlorphenamide in periodic paralysis. Neurology. 2016;86:1408-1416.
- Statland JM, Fontaine B, Hanna MG, et al. Review of the diagnosis and treatment of periodic paralysis. Muscle Nerve. 2018;57:522-530.
- Charles G, Zheng C, Lehmann-Horn F, Jurkat-Rott K, Levitt J. Characterization of hyperkalemic periodic paralysis: a survey of genetically diagnosed individuals. J Neurol. 2013;260:2606-2613.
